Skip to main content

Sanctura XR Side Effects

Generic name: trospium

Medically reviewed by Drugs.com. Last updated on May 8, 2023.

Note: This document contains side effect information about trospium. Some dosage forms listed on this page may not apply to the brand name Sanctura XR.

Applies to trospium: oral capsule extended release, oral tablet.

Serious side effects of Sanctura XR

Along with its needed effects, trospium (the active ingredient contained in Sanctura XR) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking trospium:

More common

Less common

Incidence not known

Other side effects of Sanctura XR

Some side effects of trospium may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Incidence not known

For Healthcare Professionals

Applies to trospium: oral capsule extended release, oral tablet.

Cardiovascular

Uncommon (0.1% to 1%): Tachycardia, chest pain

Frequency not reported: Tachyarrhythmia

Postmarketing reports: Palpitations, supraventricular tachycardia, chest pain, syncope, hypertensive crisis[Ref]

Gastrointestinal

Common (1% to 10%): Abdominal pain, constipation aggravated, dyspepsia, flatulence, nausea, dyspepsia, abdominal distension

Uncommon (0.1% to 1%): Abdominal distention, vomiting, dry throat, diarrhea

Postmarketing reports: Gastritis[Ref]

Nervous system

Common (1% to 10%): Headache

Uncommon (0.1% to 1%): Dysgeusia

Rare (less than 0.1%): Dizziness[Ref]

Ocular

Common (1% to 10%): Dry eyes

Uncommon (0.1% to 1%): Blurred vision

Rare (less than 0.1%): Vision disorders

Postmarketing reports: Vision abnormal[Ref]

Psychiatric

Postmarketing reports: Confusion, hallucinations, somnolence, delirium, agitation[Ref]

Other

Common (1% to 10%): Fatigue[Ref]

Dermatologic

Uncommon (0.1% to 1%): Dry skin

Rare (0.01% to 0.1%): Rash

Very rare (less than 0.01%): Angioedema

Frequency not reported: Pruritus, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)[Ref]

Hypersensitivity

Frequency not reported: Anaphylactic reaction[Ref]

Immunologic

Common (1% to 10%): Influenza[Ref]

Musculoskeletal

Rare (less than 0.1%): Myalgia, arthralgia

Postmarketing reports: Rhabdomyolysis[Ref]

Hepatic

Frequency not reported: Mild to moderate increase in serum transaminase levels[Ref]

Respiratory

Common (1% to 10%): Nasopharyngitis, nasal dryness

Frequency not reported: Dyspnea[Ref]

References

1. Product Information. Sanctura (trospium). Odyssey Pharmaceuticals.

2. Lopez Pereira P, Miguelez C, Caffarati J, Estornell F, Anguera A. Trospium chloride for the treatment of detrusor instability in children. J Urol. 2003;170:1978-81.

3. Epstein BJ, Gums JG, Molina E. Newer agents for the management of overactive bladder. Am Fam Physician. 2006;74:2061-8.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.